• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-120/I16-40
Medical Device Problem Codes Leak/Splash (1354); Material Puncture/Hole (1504); Material Integrity Problem (2978)
Health Effect - Clinical Codes Aneurysm (1708); Failure of Implant (1924); Pain (1994)
Date of Event 10/16/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was initial implanted on (b)(6) 2010 with a bifurcated stent graft and three (3) stent graft extensions the patient returned three (3) years post-initial implant ((b)(6) 2013) with a type 3a endoleak and secondary re-intervention was completed where an aortic extension was placed.On (b)(6) 2018, the patient was presented with a type ii endoleak and another re-intervention occurred where the stent graft was relined with an afx2 bifurcated stent graft and the branches of the right hypogastric artery were coil embolized.All of these event were previously reported.The patient has now presented emergently to the emergency room with pain, where a computerized tomography (ct) scan was performed showing the aneurysm is 15cm in diameter in the presence of a type iiib endoleak.The patient have refused further treatment.The patient has had multiple repairs with a re-line and has elected to go into hospice.The primary device used for this complaint will be from the last intervention where the original graft was relined with afx2 bifurcated stent graft.As of the date of this report, there have been no additional patient sequelae reported.
 
Additional Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.A clinical assessment of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Several attempts were made to obtain medical records and/ or images but no response was received.As such, event determination, off label conditions, related patient harms and patient disposition could not be independently assessed.No additional investigation of this reported event is planned.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8072156
Report Number2031527-2018-00861
Device Sequence Number16503715
Product Code MIH
UDI-Device Identifier00818009014443
UDI-Public(01)00818009014443(17)180718
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/18/2018
Device Model NumberBEA28-120/I16-40
Device Lot Number1722210-005
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/16/2018
Supplement Date Received by Manufacturer10/16/2018
Initial Report FDA Received Date11/14/2018
Supplement Report FDA Received Date01/08/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AORTIC EXTENSION, LOT # W10-1508-007; AORTIC EXTENSION, LOT # W10-1892-022; AORTIC EXTENSION, LOT # W10-1938-001; BIFURCATED STENT GRAFT, LOT # W10-1863-022; INFRARENAL EXTENSION, LOT # 1026642-011
Outcome Attributed to Adverse Event Other;
-
-